PDS Biotechnology Appoints Spencer Brown as Senior Vice President, General Counsel
yahoo.com
finance
2022-06-03 12:00:00

PDS Biotechnology Corporation

Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamune® and Infectimune™ T cell activating technologies, today announced that Spencer Brown has joined PDS Biotech as Senior Vice President, General Counsel.
